Skip to main content
. 2022 Oct 10;12(10):e068010. doi: 10.1136/bmjopen-2022-068010

Table 1.

Eligibility criteria and relevant definitions of the UK-EDI cohort

Criteria/definition Details
Inclusion criteria
  1. Aged≥50 years at the time of study entry

  2. New-onset diabetes (defined at HbA1c≥48 mmol/mol (6.5%) diagnosed within 6 months of study entry

  3. Willing to provide written informed consent prior to performing any protocol-related procedures

  4. Willing and able to comply with the protocol for the duration of the study, including scheduled follow-up visits

Exclusion criteria
  1. Diagnosis or treatment of pancreatic cancer, peri-pancreatic cancer, or pancreatic endocrine cancer

  2. Previous surgical resection of the pancreas

  3. Diagnosis of diabetes>6 months prior to study entry

  4. Pregnancy

  5. Condition preventing study investigation and follow-up

  6. Inability or incapacity to give written informed consent

Definition of new-onset diabetes HbA1c≥48 mmol/mol (6.5%) diagnosed within 6 months of study entry
Identification of PDAC diagnoses NHS digital will be interrogated to update occurrence of PDAC

HbA1c, glycated haemoglobin; PDAC, pancreatic ductal adenocarcinoma; UK-EDI, UK Early Detection Initiative for Pancreatic Cancer.